March 23, 2021 - What is the DigniCap Scalp Cooling System? Since chemotherapy affects cells that are in division and growth, all body cells can be affected. Healthy cells with a high growth rate—like hair—are more likely to be adversely affected by chemotherapy drugs. Scalp cooling is a proven approach to reduce chemotherapy-induced hair loss; reducing the temperature to the scalp decreases the blood flow to the area, allowing less chemotherapy to...

February 02, 2021 - How Johnson & Johnson Failed to Exclude Key Plaintiffs’ Experts - A Daubert claim was filed in which J & J asked that some of the experts on the Plaintiffs’ side should be disqualified as experts, therefore unable to testify. The judge in the case did not exclude these experts. The goal in this—and any other—Daubert Hearing is to evaluate whether the expert witnesses and their evidence are credible. If Johnson & Johnson had prevailed at this...

December 25, 2020 - The long-awaited Daubert decision was given by Chief Judge Wolfson, the judge overseeing the Johnson & Johnson baby powder ovarian cancer multidistrict litigation at the end of April 2020. Wolfson gave a 141-page opinion that comprehensively analyzed the factors which will determine whether scientific expert witnesses (both for the plaintiffs and for the defendants) will be allowed to testify on various issues that are critical to the cases...

November 25, 2020 - According to Drug Safety News, a recently published article in the journal Reproductive Sciences has possibly determined how talc exposure can lead to ovarian cancer. Three female scientists working at Detroit’s Wayne State University have devoted years of research in an attempt to understand how a woman’s exposure to talc can potentially lead to ovarian cancer. The researchers studied the in vitro application of talc—both to cancerous...

August 31, 2020 - CA-125 stands for Cancer Antigen 125 and is a protein that can be found in higher levels in the blood of women who have ovarian cancer. CA-125 is released into the bloodstream after being produced on the cell surfaces. In about three-quarters of women who have advanced ovarian cancer, the CA-125 will be elevated, and in about half of those with early-stage ovarian cancer, the CA-125 will be elevated. As you can see, while a CA-125 screening test...